» Articles » PMID: 38351344

Comprehensive Overview of Disease Models for Wolfram Syndrome: Toward Effective Treatments

Overview
Journal Mamm Genome
Specialty Genetics
Date 2024 Feb 13
PMID 38351344
Authors
Affiliations
Soon will be listed here.
Abstract

Wolfram syndrome (OMIM 222300) is a rare autosomal recessive disease with a devastating array of symptoms, including diabetes mellitus, optic nerve atrophy, diabetes insipidus, hearing loss, and neurological dysfunction. The discovery of the causative gene, WFS1, has propelled research on this disease. However, a comprehensive understanding of the function of WFS1 remains unknown, making the development of effective treatment a pressing challenge. To bridge these knowledge gaps, disease models for Wolfram syndrome are indispensable, and understanding the characteristics of each model is critical. This review will provide a summary of the current knowledge regarding WFS1 function and offer a comprehensive overview of established disease models for Wolfram syndrome, covering animal models such as mice, rats, flies, and zebrafish, along with induced pluripotent stem cell (iPSC)-derived human cellular models. These models replicate key aspects of Wolfram syndrome, contributing to a deeper understanding of its pathogenesis and providing a platform for discovering potential therapeutic approaches.

Citing Articles

Insights on the Genetic and Phenotypic Complexities of Optic Neuropathies.

DEsposito F, Zeppieri M, Cordeiro M, Capobianco M, Avitabile A, Gagliano G Genes (Basel). 2025; 15(12.

PMID: 39766826 PMC: 11675667. DOI: 10.3390/genes15121559.


The double whammy of ER-retention and dominant-negative effects in numerous autosomal dominant diseases: significance in disease mechanisms and therapy.

Gariballa N, Mohamed F, Badawi S, Ali B J Biomed Sci. 2024; 31(1):64.

PMID: 38937821 PMC: 11210014. DOI: 10.1186/s12929-024-01054-1.

References
1.
Abreu D, Asada R, Revilla J, Lavagnino Z, Kries K, Piston D . Wolfram syndrome 1 gene regulates pathways maintaining beta-cell health and survival. Lab Invest. 2020; 100(6):849-862. PMC: 7286786. DOI: 10.1038/s41374-020-0408-5. View

2.
Abreu D, Stone S, Pearson T, Bucelli R, Simpson A, Hurst S . A phase Ib/IIa clinical trial of dantrolene sodium in patients with Wolfram syndrome. JCI Insight. 2021; 6(15). PMC: 8410026. DOI: 10.1172/jci.insight.145188. View

3.
Akiyama M, Hatanaka M, Ohta Y, Ueda K, Yanai A, Uehara Y . Increased insulin demand promotes while pioglitazone prevents pancreatic beta cell apoptosis in Wfs1 knockout mice. Diabetologia. 2009; 52(4):653-63. DOI: 10.1007/s00125-009-1270-6. View

4.
Angebault C, Fauconnier J, Patergnani S, Rieusset J, Danese A, Affortit C . ER-mitochondria cross-talk is regulated by the Ca sensor NCS1 and is impaired in Wolfram syndrome. Sci Signal. 2018; 11(553). DOI: 10.1126/scisignal.aaq1380. View

5.
Bansal V, Boehm B, Darvasi A . Identification of a missense variant in the WFS1 gene that causes a mild form of Wolfram syndrome and is associated with risk for type 2 diabetes in Ashkenazi Jewish individuals. Diabetologia. 2018; 61(10):2180-2188. DOI: 10.1007/s00125-018-4690-3. View